Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study
PHASE3CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
June 30, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
February 29, 2016
Conditions
Metabolic Syndrome X
Interventions
DRUG
Ezetimibe
Ezetimibe 10 mg/d for 12 weeks
DRUG
Placebo
Placebo for 12 weeks
Trial Locations (1)
G1V 0A6
Laval University, Québec
All Listed Sponsors
lead
Laval University
OTHER
NCT01849068 - Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study | Biotech Hunter | Biotech Hunter